A Phase I/II Trial to Assess the Tolerability of RAD 001 [everolimus] With Gefitinib in Patients With Glioblastoma Multiforme and Prostate Cancer and Efficacy in Patients With Castrate Metastatic Prostate Cancer
Phase of Trial: Phase I/II
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Everolimus (Primary) ; Gefitinib
- Indications Glioblastoma; Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Jul 2015 Results published in the Cancer.
- 02 Oct 2005 New trial record.